Deal has $13.5 million greenshoe; proceeds will fund working capital
By Devika Patel
Knoxville, Tenn., Nov. 9 - Imperva, Inc. priced an $85.5 million initial public offering of stock with a $13.5 million greenshoe in a prospectus filed Wednesday with the Securities and Exchange Commission. It expects its shares to trade on the Nasdaq under the symbol "IMPV."
The company will sell 4.75 million common shares at $18.00 apiece.
Settlement is expected on Nov. 15.
J.P. Morgan, Deutsche Bank Securities, RBC Capital Markets, Lazard Capital Markets and Pacific Crest Securities are the underwriters. Investors may include Accel Partners, Greylock Partners, Meritech Capital Partners, U.S. Venture Partners and Venrock and Shlomo Kramer.
Proceeds will be used for working capital and general corporate purposes, as well as to invest in Incapsula, a company subsidiary, and for acquisitions and investments.
Based in Redwood Shores, Calif., Imperva is a data security company.
| Issuer: | Imperva, Inc.
|
| Issue: | Common stock
|
| Amount: | $85.5 million
|
| Greenshoe: | $13.5 million
|
| Shares: | 4.75 million
|
| Price: | $18.00
|
| Warrants: | No
|
| Underwriters: | J.P. Morgan, Deutsche Bank Securities, RBC Capital Markets, Lazard Capital Markets and Pacific Crest Securities
|
| Investors: | Accel Partners, Greylock Partners, Meritech Capital Partners, U.S. Venture Partners and Venrock and Shlomo Kramer
|
| Pricing date: | Nov. 9
|
| Settlement date: | Nov. 15
|
| Stock symbol: | Nasdaq: IMPV
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
